Name: Sonoma Pharmaceuticals, Inc. (SNOA) Balance Sheet
Creator: FinSpry

Sonoma Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Sonoma Pharmaceuticals, Inc. (SNOA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Current Assets
Cash and Cash Equivalents	5.37	3.13	3.82	7.40	4.22
Cash & Short-Term Investments	5.37	3.13	3.82	7.40	4.22
Accounts Receivable	3.76	2.90	2.57	2.63	3.02
Inventory	2.92	2.72	2.86	2.66	2.53
Other Current Assets	0.60	0.59	0.75	3.75	3.22
Total Current Assets	12.65	12.88	14.30	16.43	12.98
Non-Current Assets
Property, Plant & Equipment (Net)	0.31	0.65	0.91	0.88	1.13
Other Non-Current Assets	0.15	0.07	0.07	0.71	0.88
Total Non-Current Assets	1.05	1.86	1.93	2.42	0.00
Total Assets	13.69	14.74	16.23	18.85	14.99
Current Liabilities
Accounts Payable	0.95	2.72	2.87	1.64	1.77
Short-Term Debt	0.28	0.32	0.43	0.12	0.00
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.12	0.00
Accrued Liabilities	1.74	1.42	1.46	1.06	0.79
Deferred Revenue	0.64	0.48	0.16	1.28	0.32
Other Current Liabilities	2.22	4.71	1.46	0.78	0.37
Total Current Liabilities	4.10	8.43	3.72	5.82	4.08
Non-Current Liabilities
Long-Term Debt	0.03	0.09	0.16	0.31	1.31
Other Non-Current Liabilities	5.14	4.71	4.24	3.84	3.48
Total Non-Current Liabilities	5.19	0.17	4.54	4.33	0.00
Total Liabilities	9.28	8.60	8.25	10.15	9.62
Stockholders' Equity
Common Stock	0.00	0.00	0.01	0.00	0.00
Retained Earnings	-197.81	-197.07	-192.93	-184.36	-179.28
Accumulated Other Comprehensive Income	-4.38	-2.72	-3.42	-4.31	-4.58
Additional Paid-in Capital	206.59	203.21	200.90	197.37	0.00
Shares Outstanding	1.63	0.78	0.25	0.16	0.00
Total Stockholders' Equity	4.41	6.14	7.98	8.70	5.36
Total Liabilities & Equity	13.69	14.74	16.23	18.85	0.00